Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,343 | 53 | 97.1% |
| Education | $39.95 | 1 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $399.99 | 11 | $0 (2019) |
| GENZYME CORPORATION | $277.33 | 7 | $0 (2018) |
| Alexion Pharmaceuticals, Inc. | $184.85 | 10 | $0 (2023) |
| Relypsa, Inc. | $172.78 | 8 | $0 (2020) |
| Alnylam Pharmaceuticals Inc. | $46.89 | 2 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $38.04 | 2 | $0 (2019) |
| Cumberland Pharmaceuticals, Inc. | $37.39 | 3 | $0 (2020) |
| Boston Scientific Corporation | $24.59 | 1 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $24.10 | 1 | $0 (2022) |
| Leadiant Biosciences, Inc. | $23.76 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24.59 | 1 | Boston Scientific Corporation ($24.59) |
| 2023 | $121.89 | 6 | Alnylam Pharmaceuticals Inc. ($46.89) |
| 2022 | $91.64 | 4 | Mallinckrodt Hospital Products Inc. ($24.10) |
| 2021 | $47.39 | 2 | Alexion Pharmaceuticals, Inc. ($23.83) |
| 2020 | $124.94 | 6 | Relypsa, Inc. ($57.18) |
| 2019 | $196.18 | 11 | Relypsa, Inc. ($72.23) |
| 2018 | $365.32 | 10 | Mallinckrodt LLC ($162.48) |
| 2017 | $411.23 | 14 | Mallinckrodt LLC ($197.49) |
All Payment Transactions
54 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/19/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: General - Pain Management_NMD | ||||||
| 11/17/2023 | RECORDATI_RARE_DISEASES_INC. | CYSTADROPS (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: OCULAR METABOLIC AGENT | ||||||
| 10/17/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.74 | General |
| 09/08/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Rare Disease | ||||||
| 08/24/2023 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $28.04 | General |
| Category: Genetic Disease | ||||||
| 04/25/2023 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Genetic Disease | ||||||
| 02/02/2023 | Rhythm Pharmaceuticals, Inc. | Imcivree (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Genetic Disease | ||||||
| 10/27/2022 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $23.34 | General |
| 09/08/2022 | Leadiant Biosciences, Inc. | Cystaran (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Ophthalmic | ||||||
| 07/14/2022 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: IMMUNOLOGY | ||||||
| 05/12/2022 | Exeltis, USA Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | ||||||
| 12/16/2021 | Alexion Pharmaceuticals, Inc. | Ultomiris (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Immunology | ||||||
| 11/05/2021 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 06/02/2020 | Alexion Pharmaceuticals, Inc. | Ultomiris (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Immunology | ||||||
| 05/20/2020 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Hyperkalemia | ||||||
| 03/03/2020 | Amicus Therapeutics, Inc. | GALAFOLD (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: FABRY DISEASE | ||||||
| 02/24/2020 | Relypsa, Inc. | — | Education | In-kind items and services | $39.95 | General |
| 01/31/2020 | Alexion Pharmaceuticals, Inc. | Ultomiris (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Immunology | ||||||
| 01/22/2020 | Cumberland Pharmaceuticals, Inc. | Caldolor (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Anesthesiology (Pain Management) | ||||||
| 11/18/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/03/2019 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Immunology | ||||||
| 09/04/2019 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Hyperkalemia | ||||||
| 07/01/2019 | Cumberland Pharmaceuticals, Inc. | Vibativ (Drug) | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: Infections and Infectious Diseases | ||||||
| 05/07/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 04/12/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: KRYSTEXXA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 1 | 19 | 51 | $16,269 | $4,128 |
| 2020 | 1 | 16 | 61 | $12,688 | $4,749 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 19 | 51 | $16,269 | $4,128 | 25.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 16 | 61 | $12,688 | $4,749 | 37.4% |
About Dr. Scott Williams, MD
Dr. Scott Williams, MD is a Pediatric Nephrology healthcare provider based in Pensacola, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407816341.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Williams, MD has received a total of $1,383 in payments from pharmaceutical and medical device companies, with $24.59 received in 2024. These payments were reported across 54 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,343).
As a Medicare-enrolled provider, Williams has provided services to 35 Medicare beneficiaries, totaling 112 services with total Medicare billing of $8,877. Data is available for 2 years (2020–2021), covering 2 distinct procedure/service records.
Practice Information
- Specialty Pediatric Nephrology
- Location Pensacola, FL
- Active Since 03/24/2006
- Last Updated 10/04/2024
- Taxonomy Code 2080P0210X
- Entity Type Individual
- NPI Number 1407816341
Products in Payments
- ACTHAR (Biological) $424.09
- FABRAZYME (Drug) $207.90
- Veltassa (Drug) $132.83
- SOLIRIS (Drug) $82.71
- FABRY-DISEASE (Drug) $69.43
- Ultomiris (Drug) $63.10
- GIVLAARI (Drug) $46.89
- LOKELMA (Drug) $38.04
- Cystaran (Drug) $23.76
- Crysvita (Drug) $23.56
- CYSTADROPS (Drug) $22.78
- PURIFIED CORTROPHIN GEL (Drug) $20.44
- KRYSTEXXA (Biological) $19.86
- Imcivree (Drug) $19.78
- ULTOMIRIS (Biological) $15.70
- SAMSCA (Drug) $15.34
- GALAFOLD (Drug) $14.96
- Caldolor (Drug) $13.53
- Vibativ (Drug) $11.97
- Vaprisol (Drug) $11.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.